Search Results - "Rehlinghaus, M."

PDCD1 methylation predicts response to anti–PD-1 based immunotherapy in advanced and metastatic renal cell carcinoma by Klümper, N., Ralser, D.J., Zarbl, R., Schlack, K., Schrader, A.J., Rehlinghaus, M., Hoffmann, M.J., Niegisch, G., Uhlig, A., Trojan, L., Steinestel, J., Steinestel, K., Wirtz, R.M., Kristiansen, G., Toma, M., Hölzel, M., Ritter, M., Strieth, S., Ellinger, J., Dietrich, D.

Get full text

P157 - Real world evidence from a retrospective multi-center analysis for the combination immunotherapy ipilimumab and nivolumab as first-line treatment in advanced renal cell carcinoma by Materna, L., Schlack, K., Stelmach, R., Zschäbitz, S., Neuberger, S., Aydogdu, C., Casuscelli, J., Egenolf, T., Silberg, M., Steinestel, J., Strauss, A., Kirchhoff, F., Ahrens, M., Paffenholz, P., Cathomas, R., Gossler, C., Ivanyi, P., Rehlinghaus, M., Hilser, T., Grünwald, V.

Get full text

P151 - Lenvatinib plus Pembrolizumab as first-line treatment in patients with advanced renal cell carcinoma – real world data from a retrospective multi-center analysis by Stelmach, R., Schlack, K., Neuberger, S., Muehle, C., Darr, C., Reichert, M., Flegar, L., Zengerling, F., Casuscelli, J., Cox, A., Nestler, T., Egenolf, T., Brehmer, B., Vallet, S., Ivanyi, P., Rehlinghaus, M., Neuberger, M., Paffenholz, P., Grünwald, V., Zschäbitz, S.

Get full text

Real world evidence from a retrospective multi-center analysis for the combination immunotherapy ipilimumab and nivolumab as first-line treatment in advanced renal cell carcinoma by Materna, L., Schlack, K., Stelmach, R., Zschäbitz, S., Neuberger, S., Aydogdu, C., Casuscelli, J., Egenolf, T., Silberg, M., Steinestel, J., Strauss, A., Kirchhoff, F., Ahrens, M., Paffenholz, P., Cathomas, R., Gossler, C., Ivanyi, P., Rehlinghaus, M., Hilser, T., Grünwald, V.

Get full text

Lenvatinib plus Pembrolizumab as first-line treatment in patients with advanced renal cell carcinoma – real world data from a retrospective multi-center analysis by Stelmach, R., Schlack, K., Neuberger, S., Muehle, C., Darr, C., Reichert, M., Flegar, L., Zengerling, F., Casuscelli, J., Cox, A., Nestler, T., Egenolf, T., Brehmer, B., Vallet, S., Ivanyi, P., Rehlinghaus, M., Neuberger, M., Paffenholz, P., Grünwald, V., Zschäbitz, S.

Get full text

Neue Daten zur Behandlung uroonkologischer Patienten: Update Uroonkologie 2022 by Grunewald, C., Che, Y., Lakes, J., Rehlinghaus, M., Albers, P., Niegisch, G.

“…Zusammenfassung Die Behandlung uroonkologischer Erkrankungen wird zunehmend individueller und damit auch komplexer. Neue Daten zur Systemtherapie urothelialer…”
Get full text

Results of rapid I132 or I123 or Tc99m tests in the detection of autonomy of the thyroid by Grebe, S F, Rehlinghaus, M, Müller, H, Grebe, M

Get more information